Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. from Bioeasy Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership).
May 13, 2024
Share
Wang Tianyi agreed to acquire a 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) from Bioeasy (Hainan) Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership) for approximately CNY 150 million on April 26, 2024.
Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) from Bioeasy (Hainan) Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership) on May 14, 2024.
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.
Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. from Bioeasy Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership).
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 
